This blog is part of a blog series on corporate venturing in healthcare. Feel free to check them all out here. If you want to collaborate on corporate innovation in healthcare, you can mail me here: email@example.com
Corporate innovation in healthcare
Moreover, all kinds of companies have their own corporate venturing funds investing in healthcare.
In this blog, I’ve selected some of the leading international corporate venturing-funds with an active healthcare portfolio for you.
At the end of this article, you can find some tips in case you want to cooperate with a healthcare CVC-fund.
And corporate companies looking to set up their own collaborations might learn from this HBR-article: things you can do to better work with startups (only 25% of all initiatives reach their goals!).
But first, let’s explore who’s busy in healthcare corporate venturing right now.
Here are some of the top corporate venture funds in health:
1. Google Ventures (GV):
Google Ventures is in the top 5% of all investors. GV has a balanced portfolio of seed investments up to IPO* and acquisition. Healthcare is the second largest industry in this corporate fund and counts for 78 investments (July ’19)(Source: Dealroom).
Only last summer, GV invested in Freenome (early cancer detection), Collective Health (health insurance platform), and therapeutic companies Cronos Bio (cancer), TScan Therapeutics (T-cell therapy) and BlackThorn Therapeutics (neurobehavioral health).
GV has invested in many therapeutic companies, but also in companies changing primary care such as One Medical Group (US – changing the way you visit your doctor).
Indeed, one can say Google has a masterplan for healthcare …
2. Kamet Ventures:
3. The pharma CVCs:
Patience is a great virtue for corporations that want to collaborate with starters. Pharmaceutical companies are used to working with long incubation times, but they also need to speed up their business model innovation. To do so, they invest in corporate venturing.
Leading in the pharma CVC-scene are Novartis (the most active, with no less than 112 investments and already 9 rounds in the last year), Boehringer Ingelheim (with a nice diverse portfolio and a strong geographical spread), Novo Ventures (also strong collaborations in the US and UK, besides the home market of Denmark, and with a broad perspective that also fits gaming and home living), Roche Venture Fund and SRone, the venture branch of the Belgian Glaxo Smith Kline (GSK), which mainly works from the US.
They combine an interest in biotech with artificial intelligence in health and have mainly invested in Swiss and US healthcare companies.
Yet another telecom player who is also strong in healthcare corporate venturing.
Bosch is reinventing itself: from a German technology corporation with a solid and somewhat traditional image to a very active corporate venture capitalist, with interest in health.
Notable at Bosch Ventures is that the German home market is NOT the market where they have the most CV collaborations.
7. Samsung Ventures:
The Korean technology company has a healthy interest in healthcare and shows this through collaborations in the US and Israel. The latter being a real hotspot for health innovations by the way.
8. GE Ventures:
GE has over 40 healthcare companies in its portfolio. It has a preference for start-ups in the US and Israel.
In the US, various hospitals and health systems are very active as start-up investors. Over 45 of them now have their own corporate investment fund.
In Europe, hospitals are more familiar with funding inside-out innovation, to develop in-house intellectual property for example. Structural budgets for cooperation with external entrepreneurs (outside-in innovation) is still quite new .
If you’re looking for Corporate Venturing collaboration, you should know this:
In Europe, more than half of CVC investments in all industries are made in B2B scale-ups.
Furthermore, it is also interesting to know that CVCs set up most collaborations with start-ups in their home market.
So if you are located in a country where there is not (yet) an office of a healthcare-focused CVC, the chance of setting up a successful collaboration will, unfortunately, be lower.
On the other hand: many corporate companies keep on collaborating with health startups directly from their balance sheets.
If you think the larger CV-funds above are still too much out of reach for you, let their background inspire you for the kind of SME’s you can appeal to in your home market: insurers, media companies and publishers, and telecom companies are among the potential partners.
You can also join the Euroquity-platform for free: it’s backed by BPI France and connects European startups and investors to each other. You can also join specific funding groups and challenges there.
Want know more on corporate venturing funds?
- check out the full blog-series on healthcare corporate venturing on dashplus
- Read the must-have book of Omar Mohout and Dado Van Peteghem on corporate venturing (published in 2018).
- check out this article of Sifted on CVC-funds in Europe. it includes some of the funds I mention here.
- contact me for more examples and guidance during a workshop or seminar or by trusted advise: firstname.lastname@example.org
- Join the dashplus newsletter and stay on top of the newest business ideas and models in healthcare. It’s completely FREE.
* IPO= the initial public offering of a company